Industry reports
Editor highlights

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Brazil, May 2013 (p2)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

31-80 of about 300 reports
EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • August 2013
  • by Global Data

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022 Summary Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the likelihood ...

  • Industries : Pathology
  • Countries : Brazil, Canada, Italy, France, Japan, World, United States, United Kingdom, Spain, Germany
OTC Pharmaceuticals Market Overview in Brazil

OTC Pharmaceuticals Market Overview in Brazil

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Over-the-counter Drug
  • Countries : Brazil
OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Market Overview (Market size, Segmentation and Trends Analysis)

OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 995
  • Industry report
  • August 2013
  • by MarketLine

The report includes easily comparable data on industry value, volume, sector ation and industry share, plus full five year industry projections . It examines future problems, innovations and potential ...

  • Industries : Over-the-counter Drug
  • Countries : India, Russian Federation, Brazil, China
OTC Pharmaceuticals - Top 5 Emerging Industries Market Overview (Market size, Segmentation and Trends Analysis)

OTC Pharmaceuticals - Top 5 Emerging Industries Market Overview (Market size, Segmentation and Trends Analysis)

  • $ 995
  • Industry report
  • August 2013
  • by MarketLine

The report includes easily comparable data on industry value, volume, sector ation and industry share, plus full five year industry projections . It examines future problems, innovations and potential ...

  • Industries : Over-the-counter Drug
  • Countries : India, South Africa, Brazil, China, Mexico
Bydureon (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Bydureon (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Bydureon (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Bydureon (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Lyxumia (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Lyxumia (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Lyxumia (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Lyxumia (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Januvia (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Januvia (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Januvia (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Januvia (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Onglyza (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Galvus (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Galvus (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Galvus (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Galvus (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, Europe, United States, United Kingdom
Nesina (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Nesina (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Nesina (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Nesina (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : Japan, World, Brazil, Spain, Italy, France, Germany, India, China, United States, United Kingdom, Europe
Forxiga (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Forxiga (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Forxiga (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Forxiga (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Invokana (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Invokana (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Invokana (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Invokana (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Humalog (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Humalog (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Humalog (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Humalog (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Lantus (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Lantus (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Lantus (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Lantus (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Levemir (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Levemir (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Levemir (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Levemir (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Novolog (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Novolog (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Novolog (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Novolog (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Apidra (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Apidra (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Apidra (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Apidra (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, Europe, United States, United Kingdom
PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022

PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Brazil
Albiglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Albiglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Albiglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Albiglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Actos (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Actos (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Actos (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Actos (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : Brazil, Japan, India, China, World, Spain, Italy, France, Germany, Europe, United States, United Kingdom
Byetta (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Byetta (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Byetta (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Byetta (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Understanding Brazil's Regional Health Markets

Understanding Brazil's Regional Health Markets

  • $ 1 059
  • Industry report
  • July 2013
  • by Espicom Business Intelligence

The fifth largest country in the world in terms of both area and population, Brazil has experienced rapid economic growth in recent years. And its successful bid to host the 2014 World Cup combined with ...

  • Industries : Pathology
  • Countries : Brazil
Dulaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Dulaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Dulaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Dulaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Semaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Semaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Semaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Semaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The ...

  • Industries : Pathology
  • Countries : Japan, World, Brazil, Spain, Italy, France, Germany, India, China, United States, United Kingdom, Europe
Fasiglifam (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Fasiglifam (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Fasiglifam (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Fasiglifam (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe

» View Public Reports

About 200 reports

Brazil: Brief Outlook, 2013-2014, focus on Dietary Supplement

  • Country report
  • February 2013
  • 11 pages

... Little attention has been paid to the industry that hlf operates in: the dietary supplements industry. The dietary supplements industry is a fast- growing, multi-billion niche market ...


» Read our Company Profiles

14 Companies

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Abbott Laboratories

United States

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.